These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 24912786)

  • 1. Urinary bladder cancer risk variants: recent findings and new challenges of GWAS and confirmatory studies.
    Selinski S
    Arch Toxicol; 2014 Jul; 88(7):1469-75. PubMed ID: 24912786
    [No Abstract]   [Full Text] [Related]  

  • 2. Genome-wide association studies of bladder cancer risk: a field synopsis of progress and potential applications.
    Wu X; Hildebrandt MA; Chang DW
    Cancer Metastasis Rev; 2009 Dec; 28(3-4):269-80. PubMed ID: 20016998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic variants in urinary bladder cancer: collective power of the "wimp SNPs".
    Golka K; Selinski S; Lehmann ML; Blaszkewicz M; Marchan R; Ickstadt K; Schwender H; Bolt HM; Hengstler JG
    Arch Toxicol; 2011 Jun; 85(6):539-54. PubMed ID: 21380501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Common predisposition alleles for moderately common cancers: bladder cancer.
    Kiltie AE
    Curr Opin Genet Dev; 2010 Jun; 20(3):218-24. PubMed ID: 20153630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Germline genetic markers for urinary bladder cancer risk, prognosis and treatment response.
    Grotenhuis AJ; Vermeulen SH; Kiemeney LA
    Future Oncol; 2010 Sep; 6(9):1433-60. PubMed ID: 20919828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic variants in RUNX3 and risk of bladder cancer: a haplotype-based analysis.
    Zhang Z; Wang S; Wang M; Tong N; Fu G; Zhang Z
    Carcinogenesis; 2008 Oct; 29(10):1973-8. PubMed ID: 18684727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genome-wide association studies in bladder cancer: first results and potential relevance.
    Kiemeney LA; Grotenhuis AJ; Vermeulen SH; Wu X
    Curr Opin Urol; 2009 Sep; 19(5):540-6. PubMed ID: 19553824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic variants in cell cycle control pathway confer susceptibility to bladder cancer.
    Ye Y; Yang H; Grossman HB; Dinney C; Wu X; Gu J
    Cancer; 2008 Jun; 112(11):2467-74. PubMed ID: 18361427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic variants in the death receptor 4 gene contribute to susceptibility to bladder cancer.
    Wang M; Wang M; Cheng G; Zhang Z; Fu G; Zhang Z
    Mutat Res; 2009 Feb; 661(1-2):85-92. PubMed ID: 19070628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of an enhancer region within the TP63/LEPREL1 locus containing genetic variants associated with bladder cancer risk.
    Dudek AM; Vermeulen SH; Kolev D; Grotenhuis AJ; Kiemeney LALM; Verhaegh GW
    Cell Oncol (Dordr); 2018 Oct; 41(5):555-568. PubMed ID: 29956121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GSTA1, GSTM1, GSTP1, and GSTT1 polymorphisms and susceptibility to smoking-related bladder cancer: a case-control study.
    Matic M; Pekmezovic T; Djukic T; Mimic-Oka J; Dragicevic D; Krivic B; Suvakov S; Savic-Radojevic A; Pljesa-Ercegovac M; Tulic C; Coric V; Simic T
    Urol Oncol; 2013 Oct; 31(7):1184-92. PubMed ID: 24075358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Meta-analysis of genome-wide and replication association studies on prostate cancer.
    Liu H; Wang B; Han C
    Prostate; 2011 Feb; 71(2):209-24. PubMed ID: 20690139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of XRCC1 Arg399Gln polymorphism with bladder cancer susceptibility: a meta-analysis.
    Yang D; Liu C; Shi J; Wang N; Du X; Yin Q; Wang Y
    Gene; 2014 Jan; 534(1):17-23. PubMed ID: 24176953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of TP53 Arg72Pro polymorphism in urinary bladder cancer predisposition and predictive impact of proline related genotype in advanced tumors in an ethnic Kashmiri population.
    Pandith AA; Shah ZA; Khan NP; Rasool R; Afroze D; Yousuf A; Wani S; Siddiqi M
    Cancer Genet Cytogenet; 2010 Dec; 203(2):263-8. PubMed ID: 21156242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiology and genetic susceptibility to bladder cancer.
    Wu X; Ros MM; Gu J; Kiemeney L
    BJU Int; 2008 Nov; 102(9 Pt B):1207-15. PubMed ID: 19035883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of genetic variants in microRNA-related genes and risk of bladder cancer.
    Yang H; Dinney CP; Ye Y; Zhu Y; Grossman HB; Wu X
    Cancer Res; 2008 Apr; 68(7):2530-7. PubMed ID: 18381463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urinary bladder cancer susceptibility markers. What do we know about functional mechanisms?
    Dudek AM; Grotenhuis AJ; Vermeulen SH; Kiemeney LA; Verhaegh GW
    Int J Mol Sci; 2013 Jun; 14(6):12346-66. PubMed ID: 23752272
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of death receptor 4, Caspase 3 and 5 gene polymorphism with increased risk to bladder cancer in North Indians.
    Mittal RD; Srivastava P; Mittal T; Verma A; Jaiswal PK; Singh V; Mandal RK; Mandhani A
    Eur J Surg Oncol; 2011 Aug; 37(8):727-33. PubMed ID: 21700414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Study on bladder cancer susceptibility and genetic polymorphisms of XPC, XPG, and CYP in smokers and non-smokers.
    Wen H; Feng CC; Fang ZJ; Xia GW; Jiang HW; Xu G; Huang XD; Ding Q
    Actas Urol Esp; 2013 May; 37(5):259-65. PubMed ID: 23246108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Susceptibility to urinary bladder cancer: relevance of rs9642880[T], GSTM1 0/0 and occupational exposure.
    Golka K; Hermes M; Selinski S; Blaszkewicz M; Bolt HM; Roth G; Dietrich H; Prager HM; Ickstadt K; Hengstler JG
    Pharmacogenet Genomics; 2009 Nov; 19(11):903-6. PubMed ID: 19801959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.